Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
Arturo Casadevall, Liise‐anne Pirofski, Michael J. Joyner
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 77

Showing 51-75 of 77 citing articles:

Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
Stephen A. Klassen, Jonathon W. Senefeld, Katherine A. Senese, et al.
SSRN Electronic Journal (2021)
Open Access | Times Cited: 6
Transfusion of hyperimmune plasma for protecting foals against Rhodococcus equi pneumonia
Susanne K. Kahn, Noah D. Cohen, Angela I. Bordin, et al.
Equine Veterinary Journal (2022) Vol. 55, Iss. 3, pp. 376-388
Closed Access | Times Cited: 4
Convalescent Plasma for Covid-19–Induced ARDS
Jonathon W. Senefeld, Jeffrey P. Henderson, Michael J. Joyner
New England Journal of Medicine (2024) Vol. 390, Iss. 4, pp. 384-386
Open Access
Advances in understanding immunity to Rhodococcus equi infection and vaccine development strategies: A comprehensive review
Punit Jhandai, Karthigayan Shanmugasundaram, T. K. Bhattacharya, et al.
The Microbe (2024) Vol. 3, pp. 100077-100077
Open Access
Lack of memory recall in human CD4 T cells elicited by the first encounter with SARS-CoV-2
Katherine A. Richards, Siriruk Changrob, Paul G. Thomas, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109992-109992
Open Access
The Logic and History of Passive Immunity and Antibody Therapies
Arturo Casadevall, Nigel Paneth
Current topics in microbiology and immunology (2024)
Closed Access
The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness
Cynthia So‐Osman, Thierry Burnouf, Arwa Z. Al‐Riyami, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Development of a nomogram for high antibody titre of COVID-19 convalescent plasma
Shichun Wang, Jie Yan, Min-Sun Song, et al.
Epidemiology and Infection (2024) Vol. 152
Open Access
Efficient and Sustainable Platform for Preparation of a High-Quality Immunoglobulin G as an Urgent Treatment Option During Emerging Virus Outbreaks
Tihana Kurtović, Sanda Ravlić, Adela Štimac, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Comparison of CD3e Antibody and CD3e-sZAP Immunotoxin Treatment in Mice Identifies sZAP as the Main Driver of Vascular Leakage
Shihyoung Kim, Rajni Kant Shukla, Eunsoo Kim, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1221-1221
Open Access | Times Cited: 3
Improved Outcomes for Infants and Young Children Undergoing Lung Transplantation at Three Years of Age and Younger
Ernestina Melicoff, David R. Spielberg, Jeffrey S. Heinle, et al.
Annals of the American Thoracic Society (2022) Vol. 20, Iss. 2, pp. 254-261
Closed Access | Times Cited: 3
Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection
Mohammad A. I. Al-Hatamleh, Mai Abdel Haleem Abusalah, Ma’mon M. Hatmal, et al.
Journal of Taibah University Medical Sciences (2022) Vol. 18, Iss. 3, pp. 600-638
Open Access | Times Cited: 3
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial
Han-Sol Park, Anna Yin, Caelan Barranta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
The Changing Trajectory of Covid-19 and How Immunity is Evolving with It
Azizul Haque, Anudeep B. Pant
(2023)
Open Access | Times Cited: 1
Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019
Emma Bainbridge, Priscilla Y. Hsue, Jonathan H. Esensten, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 8
Open Access | Times Cited: 3
Pharmacokinetics of convalescent plasma therapy in a COVID-19 patient with X-linked Agammaglobulinemia
Jennifer L. Yates, David S. Palat, M. Kristina Subik, et al.
Clinical Immunology Communications (2022) Vol. 2, pp. 57-61
Open Access | Times Cited: 2
Corona virus disease – a short review
Maryam Ghaffar, Ume Habiba, Muhammad Akram Choohan
Journal of Contemporary Pharmacy (2022) Vol. 5, Iss. 2, pp. 75-79
Open Access | Times Cited: 2
COVID-19 convalescent plasma therapy through the lens of the third year of the pandemic
Liise-anne Pirofski
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 2, pp. 130-132
Open Access | Times Cited: 2
Comparison of allocation strategies of convalescent plasma to reduce excess infections and mortality from SARS‐CoV‐2 in a US‐like population
Natalya Kostandova, Emmanuel F. Drabo, Karine Yenokyan, et al.
Transfusion (2022) Vol. 63, Iss. 1, pp. 92-103
Open Access | Times Cited: 2
Health impact and cost of COVID-19 prophylaxis with monoclonal antibodies
Abraham D. Flaxman, Rodal Issema, Ruanne V. Barnabas, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients—An Open-Label Phase II Clinical Trial
Rada M. Grubovic Rastvorceva, Sedula Useini, Milena Stevanovic, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1565-1565
Open Access | Times Cited: 1
Towards a 21st century renaissance for passive immunity?
Michael J. Joyner
EBioMedicine (2023) Vol. 92, pp. 104626-104626
Open Access
Antibodies against SARS-CoV-2 control complement-induced inflammatory responses to SARS-CoV-2
Marta Bermejo‐Jambrina, Lieve E. H. van der Donk, John L. van Hamme, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Equine Polyclonal Antibodies Prevent Acute Chikungunya Virus Infection in Mice
Douglas Barker, Xiaobing Han, Eryu Wang, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1479-1479
Open Access
Molecular Docking Studies of Coronavirinae with Different Toll-Like Receptors (TLR 1-10)
Alisha Marcelle C. Aquino, Lemmuel L. Tayo, Peter Matthew Paul Fowler
(2023), pp. 212-217
Closed Access

Scroll to top